December 2021

Fetal MRI scans provide value when trying to learn more about congenital heart defects ()
FDA approves inclisiran, a twice-yearly injection that lowers cholesterol ()
Researchers take a fresh look at how different risk factors impact the look of a patient's heart ()
As healthcare leaders look ahead to 2022, preparation and planning are the keys to success ()
COVID-19 vaccines tied to greater risk of myocarditis or myopericarditis—but specialists highlight the benefits of vaccination ()
Premature heart attack deaths more common among Black, male and rural patients ()
Apixaban linked to lower bleeding risk than rivaroxaban for patients with nonvalvular AFib ()
An industry first: FDA authorizes marketing of laser-assisted IVC filter removal device ()
FDA approves rivaroxaban for treating, preventing blood clots in pediatric patients ()
Tafamidis boosts survival for patients with transthyretin amyloid cardiomyopathy ()
AECG monitoring helps identify when TAVR patients may require a permanent pacemaker ()
DOACs underprescribed among high-risk AFib patients ()
Cardiologists report an average 2021 salary of $538K, up 2% from 2020, as pandemic continues ()
Edwards gains FDA approval for new Sapien 3 solution for TPV replacement ()
Metoprolol demonstrates value as a treatment for obstructive hypertrophic cardiomyopathy ()
AI improves detection of severe CAD in stress echocardiograms ()
CDC now recommends Moderna, Pfizer/BioNTech COVID-19 vaccines over Johnson & Johnson’s due to risk of fatal blood clots ()
Cardiologist interviewed by Joe Rogan claims U.S. withheld early COVID-19 treatments to promote fear, push support for vaccines ()
Decades of data help researchers recommend the optimal HFrEF treatment ()
Heart transplants from adult donors after circulatory death yield positive outcomes ()
What happens when TAVR patients also require a peripheral vascular intervention ()
FDA announces Class I recall of intra-aortic balloon pumps after 1 death, 71 complaints ()
American Heart Association investing $10 million to study the long-term consequences of COVID-19 ()
Cardiovascular surgeon wants to sue hospital after he was fired for refusing COVID-19 vaccine ()
Medtronic receives warning letter from FDA after inspection, sees stock prices drop 7% ()
Cardiac imaging specialists receive more than $20M in new funding ()
How treatment decisions can impact young adults with PAD and advanced femoropopliteal disease ()
A key difference between stroke symptoms for men and women ()
Treating high blood pressure during pregnancy is safe and effective, new scientific statement confirms ()
Surgery journal appoints first female editor-in-chief ()
Senators to question cardiologist Robert Califf, Biden’s nominee to lead FDA, on industry ties and COVID-19 response ()
What new research tells us about HIV and heart failure ()
Heart attack survivors with kidney issues face a greater risk of heart failure ()
Cardiologists enthusiastic as House passes bill to ramp up valvular heart disease research ()
Prosthetic-patient mismatch after TAVR much less likely among Asian patients ()
Breathlessness among patients with long COVID may be a sign of heart damage ()
New ACC/AHA guidelines detail updated recommendations for PCI, CABG ()
Pre-TAVR pulmonary artery dilatation helps identify high-risk patients ()
Physicians could save $641M per year by prescribing generic CVD medications ()
Exposure to even small amounts of toxic metals increases the risk of clogged arteries ()
Cardiologist back at work after testing positive for Omicron COVID-19 variant ()
Cardiologists support legislation that would limit costly Medicare cuts ()
Catheter ablation 'significantly superior' to drug therapy when treating AFib ()
‘Surprising’ trends in ICD use among HCM patients ()
Autopsies suggest we still have a lot to learn about COVID-19's impact on the heart ()
TTVR patients see consistent improvements in their daily lives ()
Researchers 'really enthusiastic' about potential breakthrough in the treatment of vascular disease ()
American Heart Association supports new ‘surprise billing’ legislation, but physician groups have serious doubts ()
TEVAR outcomes don't suffer when performed at low-volume hospitals ()
KCCQ-12 scores a valuable asset for managing patients with acute HF ()
AI model predicts patient survival after cardiac surgery ()
Pressure-regulated THV deployment could provide significant value ()
As Omicron variant spreads, American Heart Association highlights continued support of COVID-19 vaccination ()
What new valve-in-valve TAVR data tell us about valve durability ()
Most young people with vaccine-related myocarditis recover quickly ()
Predicting AFib recurrence after catheter ablation remains a challenge ()
SAVR a valuable treatment option for asymptomatic patients with severe AS ()
Elevated heart rate tied to a greater risk of dementia ()
Ultra-processed foods increase the risk of a repeat heart attack or stroke ()
Medicare spending on cardiology, interventional cardiology declined $906M in 2020 ()
2 new studies confirm the ‘very low’ risk of myocarditis after COVID-19 vaccination ()
Predicting when T2D patients may experience a cardiovascular event ()
DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib ()
How major life events can take a toll on the heart ()
Cardiologist shares story after testing positive for Omicron COVID-19 variant—says he caught it during cardiology conference ()
SGLT2 inhibitors lower risk of HFpEF, new meta-analysis confirms ()
FDA announces Class I recall of percutaneous thrombolytic device after multiple complaints ()
Trying to anticipate major AFib events among HCM patients ()
New data on the link between COVID-19 vaccines and myopericarditis ()